Innospec [IOSP] vs Sherwin-Williams [SHW] Detailed Stock Comparison
Innospec
NASDAQ
Loading...
Sherwin-Williams
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Innospec wins in 7 metrics, Sherwin-Williams wins in 13 metrics, with 0 ties. Sherwin-Williams appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Innospec | Sherwin-Williams | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 101.95 | 33.46 | Sherwin-Williams |
| Price-to-Book Ratio | 1.51 | 19.05 | Innospec |
| Debt-to-Equity Ratio | 3.79 | 308.57 | Innospec |
| PEG Ratio | -4.11 | -2.33 | Innospec |
| EV/EBITDA | 29.71 | 22.55 | Sherwin-Williams |
| Profit Margin (TTM) | 1.08% | 11.03% | Sherwin-Williams |
| Operating Margin (TTM) | 7.96% | 17.46% | Sherwin-Williams |
| EBITDA Margin (TTM) | 7.96% | 17.46% | Sherwin-Williams |
| Return on Equity | 1.55% | 62.43% | Sherwin-Williams |
| Return on Assets (TTM) | 0.53% | 9.34% | Sherwin-Williams |
| Free Cash Flow (TTM) | $122.20M | $2.08B | Sherwin-Williams |
| Dividend Yield | 1.97% | 0.67% | Innospec |
| 1-Year Return | -32.91% | -12.08% | Sherwin-Williams |
| Price-to-Sales Ratio (TTM) | 1.09 | 3.65 | Innospec |
| Enterprise Value | $1.74B | $97.16B | Sherwin-Williams |
| EV/Revenue Ratio | 0.97 | 4.21 | Innospec |
| Gross Profit Margin (TTM) | 28.02% | 49.38% | Sherwin-Williams |
| Revenue per Share (TTM) | $72 | $92 | Sherwin-Williams |
| Earnings per Share (Diluted) | $0.77 | $10.09 | Sherwin-Williams |
| Beta (Stock Volatility) | 1.02 | 1.20 | Innospec |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Innospec vs Sherwin-Williams Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Innospec | -3.11% | -2.95% | -8.69% | -14.50% | -15.12% | -29.12% |
| Sherwin-Williams | -0.12% | -3.11% | -7.79% | -5.21% | -0.90% | 0.02% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Innospec | -32.91% | -14.64% | 10.92% | 43.62% | 362.08% | 893.36% |
| Sherwin-Williams | -12.08% | 65.21% | 43.77% | 311.08% | 1,288.42% | 2,209.22% |
News Based Sentiment: Innospec vs Sherwin-Williams
Innospec
News based Sentiment: NEUTRAL
The announcement of an earnings release date is a standard practice and doesn't inherently signal positive or negative performance. It's a procedural update that sets the stage for a more substantial information release on November 4th and 5th, 2025, making it moderately important for investors to be aware of.
Sherwin-Williams
News based Sentiment: MIXED
October presented a mixed bag for Sherwin-Williams, with a large acquisition offset by disappointing earnings and cautious financial maneuvering. While the Suvinil deal offers long-term potential, near-term headwinds and mixed analyst sentiment create uncertainty, making it a significant but complex month for investors.
Performance & Financial Health Analysis: Innospec vs Sherwin-Williams
| Metric | IOSP | SHW |
|---|---|---|
| Market Information | ||
| Market Cap | $1.97B | $84.17B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 243,158 | 1,484,380 |
| 90 Day Avg. Volume | 217,616 | 1,696,370 |
| Last Close | $73.92 | $332.81 |
| 52 Week Range | $73.72 - $128.35 | $308.84 - $400.42 |
| % from 52W High | -42.41% | -16.88% |
| All-Time High | $133.71 (May 06, 2024) | $400.42 (Nov 25, 2024) |
| % from All-Time High | -44.72% | -16.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.01% |
| Quarterly Earnings Growth | -0.25% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.11% |
| Operating Margin (TTM) | 0.08% | 0.17% |
| Return on Equity (TTM) | 0.02% | 0.62% |
| Debt to Equity (MRQ) | 3.79 | 308.57 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $52.03 | $17.72 |
| Cash per Share (MRQ) | $10.74 | $1.10 |
| Operating Cash Flow (TTM) | $136.80M | $3.06B |
| Levered Free Cash Flow (TTM) | $-62,687,500 | $1.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.97% | 0.67% |
| Last 12-Month Dividend | $1.63 | $2.21 |
Valuation & Enterprise Metrics Analysis: Innospec vs Sherwin-Williams
| Metric | IOSP | SHW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 101.95 | 33.46 |
| Forward P/E | 12.54 | 26.41 |
| PEG Ratio | -4.11 | -2.33 |
| Price to Sales (TTM) | 1.09 | 3.65 |
| Price to Book (MRQ) | 1.51 | 19.05 |
| Market Capitalization | ||
| Market Capitalization | $1.97B | $84.17B |
| Enterprise Value | $1.74B | $97.16B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.97 | 4.21 |
| Enterprise to EBITDA | 29.71 | 22.55 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 1.20 |
| Book Value per Share (MRQ) | $52.03 | $17.72 |
Financial Statements Comparison: Innospec vs Sherwin-Williams
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IOSP | SHW |
|---|---|---|
| Revenue/Sales | $440.80M | $6.31B |
| Cost of Goods Sold | $315.70M | $3.20B |
| Gross Profit | $125.10M | $3.12B |
| Research & Development | $12.70M | N/A |
| Operating Income (EBIT) | $43.00M | $1.10B |
| EBITDA | $54.10M | $1.27B |
| Pre-Tax Income | $44.40M | $985.70M |
| Income Tax | $11.60M | $231.00M |
| Net Income (Profit) | $32.80M | $754.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IOSP | SHW |
|---|---|---|
| Cash & Equivalents | $299.80M | $269.80M |
| Total Current Assets | $977.10M | $6.43B |
| Total Current Liabilities | $357.60M | $8.20B |
| Long-Term Debt | $30.40M | $9.43B |
| Total Shareholders Equity | $1.27B | $4.40B |
| Retained Earnings | $1.06B | $8.11B |
| Property, Plant & Equipment | $321.50M | $2.01B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IOSP | SHW |
|---|---|---|
| Operating Cash Flow | $21.70M | $1.08B |
| Capital Expenditures | $100,000 | N/A |
| Free Cash Flow | $12.70M | $931.10M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | $-4.80M | $-518.50M |
Short Interest & Institutional Ownership Analysis
| Metric | IOSP | SHW |
|---|---|---|
| Shares Short | 334,515 | 4.31M |
| Short Ratio | 2.01 | 2.35 |
| Short % of Float | 0.02% | 0.02% |
| Average Daily Volume (10 Day) | 243,158 | 1,484,380 |
| Average Daily Volume (90 Day) | 217,616 | 1,696,370 |
| Shares Outstanding | 24.96M | 251.29M |
| Float Shares | 24.52M | 229.92M |
| % Held by Insiders | 0.01% | 0.07% |
| % Held by Institutions | 1.00% | 0.84% |
Dividend Analysis & Yield Comparison: Innospec vs Sherwin-Williams
| Metric | IOSP | SHW |
|---|---|---|
| Last 12-Month Dividend | $1.63 | $2.21 |
| Last 12-Month Dividend Yield | 1.97% | 0.67% |
| 3-Year Avg Annual Dividend | $1.48 | $2.21 |
| 3-Year Avg Dividend Yield | 0.70% | 0.23% |
| 3-Year Total Dividends | $4.45 | $6.63 |
| Ex-Dividend Date | May 20, 2025 | Mar 03, 2025 |